Form 4: Moderna's Chief Legal Officer Reports Stock Transactions

Shannon Thyme Klinger, Moderna's Chief Legal Officer, reported the vesting of restricted stock units and subsequent tax withholding, along with the grant of new stock options and restricted stock units.

Summary

• On February 28, 2025, Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc., engaged in transactions involving common stock and restricted stock units.
• These transactions included the vesting of restricted stock units, which converted into common stock on a one-for-one basis.
• Shares were withheld to satisfy tax obligations related to the vesting of these units.
• Klinger also acquired new stock options and restricted stock units that will vest over time.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document primarily reports routine stock transactions related to executive compensation. There are no explicit positive or negative implications for the company's performance.

Positives

• The grant of new stock options and restricted stock units to the Chief Legal Officer aligns her interests with the long-term success of the company.

Future Outlook

The reported transactions reflect ongoing equity-based compensation and vesting schedules for Moderna's Chief Legal Officer.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It is standard practice for publicly traded companies to report such transactions.

Comparison to Industry Standards

• Equity compensation practices, including the use of stock options and restricted stock units, are common among publicly traded biotechnology companies like Moderna.
• Vesting schedules, such as the quarterly installments described, are also typical in the industry to incentivize long-term commitment.
• Comparable companies such as BioNTech, Pfizer, and Novavax also utilize similar equity compensation strategies for their executives.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they primarily reflect internal compensation arrangements.
• Shareholders may view the equity-based compensation as aligning executive interests with company performance.

Key Dates